Home > Quotes > INFI

Infinity Pharmaceuticals, Inc. Common Stock Quote & Summary Data

Get INFI Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading INFI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Infinity Pharmaceuticals, Inc. Common Stock Intraday Chart

News for INFI

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 6.20 $ 14.675
Low $ 5.80 $ 4.75

The current last sale of $5.97 is 25.68% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to patients with difficult-to-treat diseases. We combine proven scientific expertise with a passion for developing novel small molecule drugs that target disease pathways for potential applications in oncology. Our most advanced product candidate is duvelisib, also known as IPI-145, an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase, or PI3K, which is currently being evaluated for the treatment of hematologic malignancies, or blood cancers. We believe that duvelisib is the only inhibitor of PI3K-delta and gamma being investigated in Phase 3 clinical trials. We are pursuing duvelisib in oncology through a strategic collaboration with AbbVie Inc., or AbbVie. For information regarding our collaboration, please see below under the heading "AbbVie" in the section entitled "Strategic Alliances.  ... More ...  

Risk Grade

Where does INFI fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?